Cohen-Rosenblum A, Cui Q. Osteonecrosis of the Femoral Head. Orthop Clin North Am, 2019; 50: 139-149.
 Petek D, Hannouche D, Suva D. Osteonecrosis of the femoral head: pathophysiology and current concepts of treatment. EFORT Open Rev, 2019; 4: 85-97.
 Papakostidis C, Tosounidis TH, Jones E, Giannoudis PV. The role of "cell therapy" in osteonecrosis of the femoral head. A systematic review of the literature and meta-analysis of 7 studies. Acta Orthop, 2016; 87: 72-8.
 Liu LH, Zhang QY, Sun W, Li ZR, Gao FQ. Corticosteroid-induced Osteonecrosis of the Femoral Head: Detection, Diagnosis, and Treatment in Earlier Stages. Chin Med J (Engl), 2017; 130: 2601-2607.
 Chinese Guideline for the Diagnosis and Treatment of Osteonecrosis of the Femoral Head in Adults. Orthop Surg, 2017; 9: 3-12.
 Issa K, Pivec R, Kapadia BH, Banerjee S, Mont MA. Osteonecrosis of the femoral head: the total hip replacement solution. Bone Joint J, 2013; 95-b: 46-50.
 Gao YS, Ai ZS, Zhu ZH, Yu XW, Zhang CQ. Injury-to-surgery interval does not affect postfracture osteonecrosis of the femoral head in young adults: a systematic review. Eur J Orthop Surg Traumatol, 2013; 23: 203-9.
 Guideline for Diagnostic and Treatment of Osteonecrosis of the Femoral Head. Orthop Surg, 2015; 7: 200-7.
 Larson E, Jones LC, Goodman SB, Koo KH, Cui Q. Early-stage osteonecrosis of the femoral head: where are we and where are we going in year 2018? Int Orthop, 2018; 42: 1723-1728.
 Liu J, Zhang Z, Guo Q, Dong Y, Zhao Q, Ma X. Syringin prevents bone loss in ovariectomized mice via TRAF6 mediated inhibition of NF-kappaB and stimulation of PI3K/AKT. Phytomedicine, 2018; 42: 43-50.
 Zhang Q, Yang F, Chen Y, Wang H, Chen D, He W, Chen P. Chinese herbal medicine formulas as adjuvant therapy for osteonecrosis of the femoral head: A systematic review and meta-analysis of randomized controlled trials. Medicine (Baltimore), 2018; 97: e12196.
 Li S, Zhang B. Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med, 2013; 11: 110-20.
 Ning K, Zhao X, Poetsch A, Chen WH, Yang J. Computational Molecular Networks and Network Pharmacology. Biomed Res Int, 2017; 2017: 7573904.
 Ye H, Wei J, Tang K, Feuers R, Hong H. Drug Repositioning Through Network Pharmacology. Curr Top Med Chem, 2016; 16: 3646-3656.
 Zhang W, Bai Y, Wang Y, Xiao W. Polypharmacology in Drug Discovery: A Review from Systems Pharmacology Perspective. Curr Pharm Des, 2016; 22: 3171-81.
 Zhang R, Zhu X, Bai H, Ning K. Network Pharmacology Databases for Traditional Chinese Medicine: Review and Assessment. Front Pharmacol, 2019; 10: 123.
 Wu CW, Lu L, Liang SW, Chen C, Wang SM. [Application of drug-target prediction technology in network pharmacology of traditional Chinese medicine]. Zhongguo Zhong Yao Za Zhi, 2016; 41: 377-382.
 Ru J, Li P, Wang J, Zhou W, Li B, Huang C, Li P, Guo Z, Tao W, Yang Y, Xu X, Li Y, Wang Y, Yang L. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform, 2014; 6: 13.
 Liu Z, Guo F, Wang Y, Li C, Zhang X, Li H, Diao L, Gu J, Wang W, Li D, He F. BATMAN-TCM: a Bioinformatics Analysis Tool for Molecular mechANism of Traditional Chinese Medicine. Sci Rep, 2016; 6: 21146.
 Trott O, Olson AJ. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem, 2010; 31: 455-61.
 Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop, 2015; 6: 590-601.
 Baig SA, Baig MN. Osteonecrosis of the Femoral Head: Etiology, Investigations, and Management. Cureus, 2018; 10: e3171.
 Liu ZH, Sun XB. [Network pharmacology: new opportunity for the modernization of traditional Chinese medicine]. Yao Xue Xue Bao, 2012; 47: 696-703.
 Yu T, Zhang Z, Xie L, Ke X, Liu Y. The influence of traditional Chinese medicine constitutions on the potential repair capacity after osteonecrosis of the femoral head. Complement Ther Med, 2016; 29: 89-93.
 Yeh YA, Chiang JH, Wu MY, Tsai CH, Hsu HC, Hsu HC, Lin TL. Association of Traditional Chinese Medicine Therapy with Risk of Total Hip Replacement in Patients with Nontraumatic Osteonecrosis of the Femoral Head: A Population-Based Cohort Study. Evid Based Complement Alternat Med, 2019; 2019: 5870179.
 Boezio B, Audouze K, Ducrot P, Taboureau O. Network-based Approaches in Pharmacology. Mol Inform, 2017; 36.
 Pang XG, Cong Y, Bao NR, Li YG, Zhao JN. Quercetin Stimulates Bone Marrow Mesenchymal Stem Cell Differentiation through an Estrogen Receptor-Mediated Pathway. Biomed Res Int, 2018; 2018: 4178021.
 Zhou Y, Wu Y, Jiang X, Zhang X, Xia L, Lin K, Xu Y. The Effect of Quercetin on the Osteogenesic Differentiation and Angiogenic Factor Expression of Bone Marrow-Derived Mesenchymal Stem Cells. PLoS One, 2015; 10: e0129605.
 Wang C, Wang Y, Meng HY, Yuan XL, Xu XL, Wang AY, Guo QY, Peng J, Lu SB. Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head. Int J Clin Exp Med, 2015; 8: 3127-35.
 Li R, Lin QX, Liang XZ, Liu GB, Tang H, Wang Y, Lu SB, Peng J. Stem cell therapy for treating osteonecrosis of the femoral head: From clinical applications to related basic research. Stem Cell Res Ther, 2018; 9: 291.
 Zhao D, Liu Y, Ma C, Gu G, Han DF. A Mini Review: Stem Cell Therapy for Osteonecrosis of the Femoral Head and Pharmacological Aspects. Curr Pharm Des, 2019; 25: 1099-1104.
 Kuroda Y, Kawai T, Goto K, Matsuda S. Clinical application of injectable growth factor for bone regeneration: a systematic review. Inflamm Regen, 2019; 39: 20.
 Zou D, Zhang K, Yang Y, Ren Y, Zhang L, Xiao X, Zhang H, Liu S, Li J. Th17 and IL-17 exhibit higher levels in osteonecrosis of the femoral head and have a positive correlation with severity of pain. Endokrynol Pol, 2018; 69: 283-290.
 Hong JM, Kim TH, Chae SC, Koo KH, Lee YJ, Park EK, Choi JY, Ryoo HM, Kim SY. Association study of hypoxia inducible factor 1alpha (HIF1alpha) with osteonecrosis of femoral head in a Korean population. Osteoarthritis Cartilage, 2007; 15: 688-94.
 Ma W, Xin K, Chen K, Tang H, Chen H, Zhi L, Liu H. Relationship of common variants in VEGFA gene with osteonecrosis of the femoral head: A Han Chinese population based association study. Sci Rep, 2018; 8: 16221.
 Shao J, Zhang Y, Yang T, Qi J, Zhang L, Deng L. HIF-1alpha disturbs osteoblasts and osteoclasts coupling in bone remodeling by up-regulating OPG expression. In Vitro Cell Dev Biol Anim, 2015; 51: 808-14.
 Stegen S, van Gastel N, Eelen G, Ghesquiere B, D'Anna F, Thienpont B, Goveia J, Torrekens S, Van Looveren R, Luyten FP, Maxwell PH, Wielockx B, Lambrechts D, Fendt SM, Carmeliet P, Carmeliet G. HIF-1alpha Promotes Glutamine-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics to Support Postimplantation Bone Cell Survival. Cell Metab, 2016; 23: 265-79.
 Yu J, Liang F, Huang H, Pirttiniemi P, Yu D. Effects of loading on chondrocyte hypoxia, HIF-1alpha and VEGF in the mandibular condylar cartilage of young rats. Orthod Craniofac Res, 2018; 21: 41-47.
 Xu J, Sun Y, Wu T, Liu Y, Shi L, Zhang J, Kang Q, Chai Y, Li G. Enhancement of bone regeneration with the accordion technique via HIF-1alpha/VEGF activation in a rat distraction osteogenesis model. J Tissue Eng Regen Med, 2018; 12: e1268-e1276.
 Hu K, Olsen BR. Osteoblast-derived VEGF regulates osteoblast differentiation and bone formation during bone repair. J Clin Invest, 2016; 126: 509-26.